113 related articles for article (PubMed ID: 10962552)
1. The activation loop in Lck regulates oncogenic potential by inhibiting basal kinase activity and restricting substrate specificity.
Laham LE; Mukhopadhyay N; Roberts TM
Oncogene; 2000 Aug; 19(35):3961-70. PubMed ID: 10962552
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between the catalytic and regulatory domains allows bidirectional regulation of Src.
Gonfloni S; Weijland A; Kretzschmar J; Superti-Furga G
Nat Struct Biol; 2000 Apr; 7(4):281-6. PubMed ID: 10742171
[TBL] [Abstract][Full Text] [Related]
3. Structure of the regulatory domains of the Src-family tyrosine kinase Lck.
Eck MJ; Atwell SK; Shoelson SE; Harrison SC
Nature; 1994 Apr; 368(6473):764-9. PubMed ID: 7512222
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the enzymatic function of the lymphocyte-specific tyrosine protein kinase p56lck by the non-catalytic SH2 and SH3 domains.
Veillette A; Caron L; Fournel M; Pawson T
Oncogene; 1992 May; 7(5):971-80. PubMed ID: 1570157
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine 192 within the SH2 domain of the Src-protein tyrosine kinase p56
Kästle M; Merten C; Hartig R; Kaehne T; Liaunardy-Jopeace A; Woessner NM; Schamel WW; James J; Minguet S; Simeoni L; Schraven B
Cell Commun Signal; 2020 Nov; 18(1):183. PubMed ID: 33225946
[TBL] [Abstract][Full Text] [Related]
6. Peptide and protein phosphorylation by protein tyrosine kinase Csk: insights into specificity and mechanism.
Sondhi D; Xu W; Songyang Z; Eck MJ; Cole PA
Biochemistry; 1998 Jan; 37(1):165-72. PubMed ID: 9425036
[TBL] [Abstract][Full Text] [Related]
7. Functional interaction of the Ras effector RASSF5 with the tyrosine kinase Lck: critical role in nucleocytoplasmic transport and cell cycle regulation.
Kumari G; Singhal PK; Suryaraja R; Mahalingam S
J Mol Biol; 2010 Mar; 397(1):89-109. PubMed ID: 20064523
[TBL] [Abstract][Full Text] [Related]
8. Domain interactions in protein tyrosine kinase Csk.
Sondhi D; Cole PA
Biochemistry; 1999 Aug; 38(34):11147-55. PubMed ID: 10460171
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation.
Yamaguchi H; Hendrickson WA
Nature; 1996 Dec; 384(6608):484-9. PubMed ID: 8945479
[TBL] [Abstract][Full Text] [Related]
10. Bacterial expression and characterization of catalytic loop mutants of SRC protein tyrosine kinase.
Kemble DJ; Wang YH; Sun G
Biochemistry; 2006 Dec; 45(49):14749-54. PubMed ID: 17144667
[TBL] [Abstract][Full Text] [Related]
11. Properties of tripartite chimeras between Src and Lck.
Kashishian A; MacAuley A; Cooper JA
Oncogene; 1990 Oct; 5(10):1463-70. PubMed ID: 2250908
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
Brasher BB; Roumiantsev S; Van Etten RA
Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
[TBL] [Abstract][Full Text] [Related]
13. The role of the linker between the SH2 domain and catalytic domain in the regulation and function of Src.
Gonfloni S; Williams JC; Hattula K; Weijland A; Wierenga RK; Superti-Furga G
EMBO J; 1997 Dec; 16(24):7261-71. PubMed ID: 9405355
[TBL] [Abstract][Full Text] [Related]
14. Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95.
Potts WM; Reynolds AB; Lansing TJ; Parsons JT
Oncogene Res; 1988; 3(4):343-55. PubMed ID: 2465527
[TBL] [Abstract][Full Text] [Related]
15. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of C-terminal Src kinase by siRNA-mediated RNA interference augments T cell receptor signaling in mature T cells.
Vang T; Abrahamsen H; Myklebust S; Enserink J; Prydz H; Mustelin T; Amarzguioui M; Tasken K
Eur J Immunol; 2004 Aug; 34(8):2191-9. PubMed ID: 15259016
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis for regulation of Src by the docking protein p130Cas.
Nasertorabi F; Tars K; Becherer K; Kodandapani R; Liljas L; Vuori K; Ely KR
J Mol Recognit; 2006; 19(1):30-8. PubMed ID: 16245368
[TBL] [Abstract][Full Text] [Related]
18. 3D-QSAR studies on c-Src kinase inhibitors and docking analyses of a potent dual kinase inhibitor of c-Src and c-Abl kinases.
Thaimattam R; Daga PR; Banerjee R; Iqbal J
Bioorg Med Chem; 2005 Aug; 13(15):4704-12. PubMed ID: 15914012
[TBL] [Abstract][Full Text] [Related]
19. Subdomain switching reveals regions that harbor substrate specificity and regulatory properties of protein tyrosine kinases.
Wang YH; Huang K; Lin X; Sun G
Biochemistry; 2007 Sep; 46(35):10162-9. PubMed ID: 17691821
[TBL] [Abstract][Full Text] [Related]
20. Detection of a physical and functional interaction between Csk and Lck which involves the SH2 domain of Csk and is mediated by autophosphorylation of Lck on tyrosine 394.
Bougeret C; Delaunay T; Romero F; Jullien P; Sabe H; Hanafusa H; Benarous R; Fischer S
J Biol Chem; 1996 Mar; 271(13):7465-72. PubMed ID: 8631775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
